SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-19-000992
Filing Date
2019-03-07
Accepted
2019-03-07 16:11:03
Documents
100
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2237804z10-k.htm 10-K 1502889
2 EX-21.1 a2237804zex-21_1.htm EX-21.1 5190
3 EX-23.1 a2237804zex-23_1.htm EX-23.1 2879
4 EX-31.1 a2237804zex-31_1.htm EX-31.1 8890
5 EX-31.2 a2237804zex-31_2.htm EX-31.2 8878
6 EX-32 a2237804zex-32.htm EX-32 7432
13 G221689.JPG g221689.jpg GRAPHIC 50500
  Complete submission text file 0001047469-19-000992.txt   8250721

Data Files

Seq Description Document Type Size
7 EX-101.INS cldx-20181231.xml EX-101.INS 1912256
8 EX-101.SCH cldx-20181231.xsd EX-101.SCH 60688
9 EX-101.CAL cldx-20181231_cal.xml EX-101.CAL 75014
10 EX-101.LAB cldx-20181231_lab.xml EX-101.LAB 598818
11 EX-101.PRE cldx-20181231_pre.xml EX-101.PRE 480482
12 EX-101.DEF cldx-20181231_def.xml EX-101.DEF 254975
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 19665956
SIC: 2835 In Vitro & In Vivo Diagnostic Substances